|Bid||38.73 x 900|
|Ask||41.73 x 1100|
|Day's Range||37.79 - 39.88|
|52 Week Range||37.79 - 70.82|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 03, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||61.11|
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -15.09% and 22.59%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ending March 31, 2021.
NEW YORK, NY / ACCESSWIRE / May 4, 2021 / PTC Therapeutics, Inc. (NASDAQ:PTCT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021 at 4:30 PM Eastern Time.